There's a growing need for improved access to medication-assisted treatment among patients with opioid use disorder, according to a new study presented at the American Society of Addiction Medicine 47th Annual Conference.
After heavy criticism by Congress, presidential candidates and others, Valeant Pharmaceuticals is offering a discount program on its heart drugs Nitropress and Isuprel.
Surprisingly, Medicare beneficiaries are likely to pay much more for biosimilars than the referenced brand medication, according to a new report.
Diabetes prevention program found to improve quality and reduces healthcare costs. It will now be covered by Medicare in 2017.
FDA issued a draft guidance to support industry in their development of generic versions of approved opioids with abuse-deterrent formulations (ADF), while ensuring that generic ADF opioids are no less abuse-deterrent than the brand-...
Spending on brand name drugs spiked 16.2% in 2015 and 98.2% since 2011, according to a new report from pharmacy benefit manager (PBM) Express Scripts. Plus, a third of branded products experienced price increases greater than 20% in...

FDA APPROVALS
FDA approves first treatment for acute GVHD

FDA just granted Breakthrough Therapy Designation for the first treatment for acute graft-versus-host disease (GVHD): ...

FDA approves novel kidney disease drug
First US cholera vaccine available
Teva halts migraine patch sales over burns

CLINICAL
FDA approves first treatment for acute GVHD

FDA just granted Breakthrough Therapy Designation for the first treatment for acute graft-versus-host disease (GVHD): ...

FDA approves novel kidney disease drug
New kidney warning on popular diabetes drugs
First US cholera vaccine available